BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27723458)

  • 41. CBX7 Induces Self-Renewal of Human Normal and Malignant Hematopoietic Stem and Progenitor Cells by Canonical and Non-canonical Interactions.
    Jung J; Buisman SC; Weersing E; Dethmers-Ausema A; Zwart E; Schepers H; Dekker MR; Lazare SS; Hammerl F; Skokova Y; Kooistra SM; Klauke K; Poot RA; Bystrykh LV; de Haan G
    Cell Rep; 2019 Feb; 26(7):1906-1918.e8. PubMed ID: 30759399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Live-cell single-molecule dynamics of PcG proteins imposed by the DIPG H3.3K27M mutation.
    Tatavosian R; Duc HN; Huynh TN; Fang D; Schmitt B; Shi X; Deng Y; Phiel C; Yao T; Zhang Z; Wang H; Ren X
    Nat Commun; 2018 May; 9(1):2080. PubMed ID: 29802243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer.
    Li X; Gou J; Li H; Yang X
    Sci Rep; 2020 Oct; 10(1):17739. PubMed ID: 33082469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7.
    Lamb KN; Bsteh D; Dishman SN; Moussa HF; Fan H; Stuckey JI; Norris JL; Cholensky SH; Li D; Wang J; Sagum C; Stanton BZ; Bedford MT; Pearce KH; Kenakin TP; Kireev DB; Wang GG; James LI; Bell O; Frye SV
    Cell Chem Biol; 2019 Oct; 26(10):1365-1379.e22. PubMed ID: 31422906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SUMOylated PRC1 controls histone H3.3 deposition and genome integrity of embryonic heterochromatin.
    Liu Z; Tardat M; Gill ME; Royo H; Thierry R; Ozonov EA; Peters AH
    EMBO J; 2020 Jul; 39(13):e103697. PubMed ID: 32395866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-Guided Discovery of Selective Antagonists for the Chromodomain of Polycomb Repressive Protein CBX7.
    Ren C; Smith SG; Yap K; Li S; Li J; Mezei M; Rodriguez Y; Vincek A; Aguilo F; Walsh MJ; Zhou MM
    ACS Med Chem Lett; 2016 Jun; 7(6):601-5. PubMed ID: 27326334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The
    Raby L; Völkel P; Le Bourhis X; Angrand PO
    Genes (Basel); 2020 Mar; 11(4):. PubMed ID: 32230868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sparse CBX2 nucleates many Polycomb proteins to promote facultative heterochromatinization of Polycomb target genes.
    Ingersoll S; Trouth A; Luo X; Espinoza A; Wen J; Tucker J; Astatike K; Phiel CJ; Kutateladze TG; Wu TP; Ramachandran S; Ren X
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put.
    Simon JA; Kingston RE
    Mol Cell; 2013 Mar; 49(5):808-24. PubMed ID: 23473600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration.
    Federico A; Sepe R; Cozzolino F; Piccolo C; Iannone C; Iacobucci I; Pucci P; Monti M; Fusco A
    Biochim Biophys Acta Gene Regul Mech; 2019 Apr; 1862(4):509-521. PubMed ID: 30826432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Polycomb domain found in committed cells impairs differentiation when introduced into PRC1 in pluripotent cells.
    Jaensch ES; Zhu J; Cochrane JC; Marr SK; Oei TA; Damle M; McCaslin EZ; Kingston RE
    Mol Cell; 2021 Nov; 81(22):4677-4691.e8. PubMed ID: 34637753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How CBX proteins regulate normal and leukemic blood cells.
    de Groot AP; de Haan G
    FEBS Lett; 2024 Mar; ():. PubMed ID: 38426219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic values of distinct CBX family members in breast cancer.
    Liang YK; Lin HY; Chen CF; Zeng D
    Oncotarget; 2017 Nov; 8(54):92375-92387. PubMed ID: 29190923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.
    Wang S; Alpsoy A; Sood S; Ordonez-Rubiano SC; Dhiman A; Sun Y; Jiao G; Krusemark CJ; Dykhuizen EC
    Chembiochem; 2021 Jul; 22(13):2335-2344. PubMed ID: 33950564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Governing the Silencing State of Chromatin: The Roles of Polycomb Repressive Complex 1 in Arabidopsis.
    Yang X; Tong A; Yan B; Wang X
    Plant Cell Physiol; 2017 Feb; 58(2):198-206. PubMed ID: 28069891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-molecule imaging of epigenetic complexes in living cells: insights from studies on Polycomb group proteins.
    Brown K; Andrianakos H; Ingersoll S; Ren X
    Nucleic Acids Res; 2021 Jul; 49(12):6621-6637. PubMed ID: 34009336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CBX8 interacts with chromatin PTEN and is involved in regulating mitotic progression.
    Choi BH; Colon TM; Lee E; Kou Z; Dai W
    Cell Prolif; 2021 Nov; 54(11):e13110. PubMed ID: 34592789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polycomb repressive complex 1 controls uterine decidualization.
    Bian F; Gao F; Kartashov AV; Jegga AG; Barski A; Das SK
    Sci Rep; 2016 May; 6():26061. PubMed ID: 27181215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthetic trimethyllysine receptors that bind histone 3, trimethyllysine 27 (H3K27me3) and disrupt its interaction with the epigenetic reader protein CBX7.
    Tabet S; Douglas SF; Daze KD; Garnett GA; Allen KJ; Abrioux EM; Quon TT; Wulff JE; Hof F
    Bioorg Med Chem; 2013 Nov; 21(22):7004-10. PubMed ID: 24100156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain.
    Ren C; Morohashi K; Plotnikov AN; Jakoncic J; Smith SG; Li J; Zeng L; Rodriguez Y; Stojanoff V; Walsh M; Zhou MM
    Chem Biol; 2015 Feb; 22(2):161-8. PubMed ID: 25660273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.